These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 1064914)

  • 21. In vitro activity of the combination trimethoprim plus sulfamethoxazole compared with that of other chemotherapeutic agents.
    Focht J; Klietmann W; Nösner K
    Arzneimittelforschung; 1988 Aug; 38(8):1085-8. PubMed ID: 3264166
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Trimethoprim-sulfamethoxazole in the agar diffusion test. Comparison with tetracycline, chloramphenicol, gentamycin and sulfadiazine].
    Lentze I
    Med Klin; 1971 Nov; 66(45):1518-22. PubMed ID: 5000621
    [No Abstract]   [Full Text] [Related]  

  • 23. In vitro resistance of haemophilus influenzae to co-trimoxazole and trimethoprim.
    Cornere BM; Menzies R
    N Z Med J; 1975 Mar; 81(536):292-4. PubMed ID: 1079587
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trimethoprim and sulphamethoxazole: determination of bacterial sensitivity and drug concentration in human serum.
    Dornbusch K
    Scand J Infect Dis Suppl; 1976; (8):20-8. PubMed ID: 1064909
    [No Abstract]   [Full Text] [Related]  

  • 25. Susceptibility of obligate anaerobes to trimethoprim-sulfamethoxazole.
    Indiveri MC; Hirsh DC
    J Am Vet Med Assoc; 1986 Jan; 188(1):46-8. PubMed ID: 3484737
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Antibiotic susceptibility of E. coli strains isolated from urinary tract infections and the role of metabolically deficient strains in these infections].
    Söyletir G; Günalp A
    Mikrobiyol Bul; 1985 Oct; 19(4):210-7. PubMed ID: 3913849
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Antibacterial activity of co-trimoxazole and tetroxoprim/sulfadiazine in vitro (author's transl)].
    Hahn H; Kirov A
    Arzneimittelforschung; 1980; 30(7):1047-8. PubMed ID: 7191284
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Co-trimaxazole therapy: place and prospects.
    O'Grady FW
    Med J Aust; 1973 Jun; 1(2):Suppl:19-25. PubMed ID: 4199528
    [No Abstract]   [Full Text] [Related]  

  • 29. [In-vitro activity of Eusaprim].
    Mariani PL; Ceruti T; Biazzi E
    Minerva Med; 1973 May; 64(34):1835-8. PubMed ID: 4719380
    [No Abstract]   [Full Text] [Related]  

  • 30. Trimethoprim-sulfamethoxazole: A reappraisal.
    O'Grady F
    Can Med Assoc J; 1975 Jun; 112(13 Spec No):5-7. PubMed ID: 1079470
    [No Abstract]   [Full Text] [Related]  

  • 31. Trimethoprim-sulfamethoxazole.
    Peloquin CA
    N C Med J; 1983 Jul; 44(7):438. PubMed ID: 6604231
    [No Abstract]   [Full Text] [Related]  

  • 32. [Synergism of trimethoprim and sulfamethoxazole action on microorganisms isolated from persons with urinary tract infections].
    Ganczarski A; Augustyniak B; Kloczkowski K; Prelich A; Stapor K
    Med Dosw Mikrobiol; 1972; 24(4):307-14. PubMed ID: 4632270
    [No Abstract]   [Full Text] [Related]  

  • 33. [Studies on the microbial resistance to the drug combination sulfamethoxazole trimethroprim with special reference to enterococci].
    Gärtner H; Dieterich F
    Arzneimittelforschung; 1973 Apr; 23(4):597-600. PubMed ID: 4197072
    [No Abstract]   [Full Text] [Related]  

  • 34. Norfloxacin versus co-trimoxazole for the treatment of upper urinary tract infections: a double blind trial.
    Tungsanga K; Chongthaleong A; Udomsantisuk N; Petcharabutr OA; Sitprija V; Wong EC
    Scand J Infect Dis Suppl; 1988; 56():28-34. PubMed ID: 3074463
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trimethoprim-resistant Enterobacteriaceae in urinary tract infection.
    Wong CK; Harding GK; Ronald AR; Hoban S
    Can Med Assoc J; 1975 Jun; 112(13 Spec No):54-8. PubMed ID: 1093652
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Susceptibility of gram negative bacteria to TMP-SMX and ofloxacin].
    Unal S; Aydin M; Akin A
    Mikrobiyol Bul; 1988; 22(4):316-21. PubMed ID: 3266971
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Development of bacterial resistance against trimethoprim-sulfamethoxazole (Eusaprim)].
    Meyer-Rohn J; Liehr W
    Fortschr Med; 1974 Jan; 92(3):121-6. PubMed ID: 4206486
    [No Abstract]   [Full Text] [Related]  

  • 38. Oral ciprofloxacin in resistant urinary tract infections.
    Ryan JL; Berenson CS; Greco TP; Mangi RJ; Sims M; Thornton GF; Andriole VT
    Am J Med; 1987 Apr; 82(4A):303-6. PubMed ID: 3555052
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Antibacterial activity of a sulfonamide combination (Kelfiprim) in some otorhinolaryngological diseases].
    Serra A; Tringali G; Toscano MA; Gismondo MR; Piaia F
    G Clin Med; 1980 Dec; 61(12):906-18. PubMed ID: 7215739
    [No Abstract]   [Full Text] [Related]  

  • 40. [Nocardiosis: clinical and bacteriological aspects. Experience in 16 cases].
    Fernández M; Paredes L; Castillo M; Donoso A
    Rev Med Chil; 1987 Nov; 115(11):1053-60. PubMed ID: 3509826
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.